Trial Profile
United states CABG [coronary artery bypass surgery] diabetes project (USCDP) pilot study.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin glulisine (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 03 Feb 2009 Status changed from recruiting to not yet recruiting as reported by ClinicalTrials.gov.
- 03 Feb 2009 Planned initiation date (Mar 2009) added as reported by ClinicalTrials.gov.
- 03 Feb 2009 Planned end date changed from 1 Feb 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.